Orange Book product · Generic (ANDA)
AVANAFIL
AVANAFIL
Generic (ANDA)ANDA 209266TE ABRX HETERO LABS LTD V
At a glance
Jun 14, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 14, 2024
2 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
AVANAFIL
Strength
50MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 209266
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AVANAFIL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
